Repare Therapeutics Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 29.05 million compared to USD 106.91 million a year ago. Basic loss per share from continuing operations was USD 0.69 compared to USD 2.83 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | +3.88% | +11.54% | -52.33% |
05-08 | Top Premarket Gainers | MT |
05-08 | Repare Therapeutics Shares Rise Premarket Wednesday After Company Swings to Q1 Net Income Amid Higher Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.33% | 142M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- RPTX Stock
- News Repare Therapeutics Inc.
- Repare Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022